What the Options Market Tells Us About Regeneron Pharmaceuticals
Portfolio Pulse from Benzinga Insights
The options market shows a bullish sentiment towards Regeneron Pharmaceuticals, with 66% of trades being bullish. Analysts have mixed ratings, with price targets ranging from $1015 to $1300. The stock is currently down 1.11% at $1000.96, with an upcoming earnings report in 21 days.
October 10, 2024 | 6:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Options market indicates a bullish sentiment for Regeneron Pharmaceuticals, with 66% of trades being bullish. Analysts have mixed ratings, with price targets ranging from $1015 to $1300. The stock is currently down 1.11% at $1000.96.
The options market shows a strong bullish sentiment with 66% of trades being bullish, indicating potential upward movement. Analysts' mixed ratings and price targets suggest varied expectations, but the overall sentiment leans positive. The stock's current decline may present a buying opportunity, especially with the upcoming earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100